Drug addiction: Therapeutic problems in everyday clinical practice

Slides:



Advertisements
Similar presentations
Multicultural Wellness Center “Providing Culture Centered Treatment to Diverse Communities.”
Advertisements

2 emcdda.europa.eu European drug report package A comprehensive analysis on the drugs problem in Europe.
Module 4: Interaction of. Objectives To be aware of the possible reasons why dual diagnosis occurs To be aware of the specific effects of substances on.
Dr. Elaine Dunnea, Dr. Maura Dugganb, Dr. Julie O’Mahonyc
1 Adolescent Mental Health: Key Data Indicators Gwendolyn J. Adam, Ph.D., L.C.S.W. Assistant Professor - Department of Pediatrics Section of Adolescent.
Major findings from the 2013 World Drug Report. Drug use Overall drug use, including problem drug use, has remained largely stable over the past 5 years.
Drug use, related problems and interventions targeting drug users in prison in the European countries: main issues and challenges for the future Linda.
The UK Drugs Situation: Data, information and uses Charlotte Davies, UK Focal Point Project Manager 1.
An EMCDDA view on recovery Roland Simon Head of Unit Intervention, Best Practice, and Scientific Partners.
WORK PACKAGE TREATMENT CHALLENGES Dr.Thomas Legl Member of Executive Committee EURO –TC Director Kur- und Gesundheitszentrum Knappenhof/Austria ICAA,,
Polydrug use challenges – European experience International Conference: New trends in drug use: facts and solutions, Parliament of the Republic of Vilnius.
Annual report 2010: the state of the drugs problem in Europe.
Annual report 2009: the state of the drugs problem in Europe International Conference: New trends in drug use: facts and solutions, Parliament of the Republic.
Trends and developments Selected trends and some insights in prevention Vilnius, 12 November 2014 Roland Simon.
Chapter 3 Addictions: Theory and Treatment. Drug Addiction Behavioral pattern of drug use Overwhelming involvement Securing of its supply Tendency to.
An overview of European trends and developments Roland Simon ECAD Meeting 2011, Varna.
Access to Care/ Maintenance in Care: Service Needs and Consumer Reported Barriers Angela Aidala, Gunjeong Lee, Brooke West Mailman School of Public Health,
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.
PRINCIPLES OF DRUG ADDICTION TREATMENT Dr. K. S. NJUGUNA.
CRSI Conference Perinatal Mental Health Care Workshop Brigid Arkins
MRCPsych addiction psychiatry seminar series Policy, guidance, service structures and legal framework of addiction treatment Epidemiology of addictive.
Prison staff and harm reduction Additional module: Mental health and drug use Training Criminal Justice Professionals in Harm Reduction Services for Vulnerable.
Linda Montanari, Buenos Aires, October 2003 CICAD/OAS, Demand Reduction Experts Group Meeting The Information System on Treatment Demand in EU EMCDDA.
HIGH POINT TREATMENT CENTER High Point Treatment Center’s (H.P.T.C.) mission is to prevent and treat chemical dependency and provide therapeutic services.
Introduction Results and Conclusions Categorical group comparisons revealed no differences on demographic or social variables. At admission to treatment,
Epidemiology of addictive disorders: a brief review MRCPsych addiction psychiatry seminar series Dr Stuart McLaren 2 nd March 2012.
Special patient groups Module 5. Introduction Worldwide, the majority of people in substitute treatment are men between Even they do not form a.
Brain diseases: Substance abuse and co-occurring disorders Mark Publicker, MD FASAM.
MRCPsych addiction psychiatry seminar series Policy, guidance and legal framework of addiction treatment Classification of substance use disorders Assessment.
Exam 2 Review May 07, Today’s Agenda Exam Structure and tips Lectures # 1-17 (Chs. 9, 10, 11,13) Sample Questions Open Q&A.
Chronical Mental Illness: A Living Nightmare BY: PATRICIA L. PICKLES, Ph.D. Quevarra Moten.
Mental Health, Substance Abuse, and Older Adults Funded by Master’s Advanced Curriculum Project University of Texas at Arlington The development of this.
ANOREXIA/BULIMIA Young adolescent women, 90% female Risk groups – higher social classes, models, athletes, dancers, students, hx sexual abuse Comorbid.
TEEN HEALTH ISSUES.  Adolescents (ages 10 to 19) and young adults (ages 20 to 24) make up 21 percent of the population of the United States.  The behavioral.
Overview of the cannabis use in Europe Paul Griffiths, Reitox academy, Berlin, 29th March 2007.
Evidence on health inequality and multiple discrimination Alessio D’Angelo, Lecturer in Social Sciences, Middlesex University.
Alcohol and Drug Problem in Poland. Implications for policy Janusz Sierosławski Institute of Psychiatry i Neurology 3rd Meeting of the Expert Group on.
Terms Related to Substance Abuse
Deadly trio: mental health – HIV - drugs
Current Mental Health Care Systems
Mental and Behavioral Health Services
Schizophrenia: an inside view
Young people, substance misuse and PHE
Mental Health, Substance Abuse, and Older Adults
ESPAD Report 2015 Results from the European School Survey Project on Alcohol and Other Drugs ESPAD Group Lisbon, 20 September 2016.
US Census Data Ortman, Jennifer M., Victoria A. Velkoff, and Howard Hogan. An Aging Nation: The Older Population in the United States, Current Population.
National Health Reform is Essential
6% of adults had used one or more illicit drugs in last 12 months.
The extent of illness, injury, or disability in a defined population.
InnovaTel Telepsychiatry
Kristen Williams, Jonathan J.K. Stoltman, and Mark K. Greenwald
Lung cancer prevalence on the rise (Nov. 2014)
The Burden of Tobacco Use
MODULE 2- EPIDEMIOLOGY OF DRUG USE IN THE AMERICAS
Reitox National Focal Point National Bureau for Drug Prevention
The Scope of the Problem
The social epidemiology of alcohol and drug use among Israeli school-aged children: Recent developments and current challenges Prof. Yossi Harel-Fisch.
Chapter 8 Adolescents, Young Adults, and Adults
The European Experience: Prescription Drug Misuse in France, Germany, Italy and Spain 24 October 2017 Presented at Lisbon Addictions 2017 Jody L. Green,
Module 1: Putting Drugs of Abuse and Clients in Perspective
Diabetes and Psychiatric Disorders: Can they Co-exist?
About the Provincial System Support Program
Addressing dual diagnosis within a residential treatment programme serving women with complex needs Anita Harris.
Epidemiological Terms
ADDICTION
2008 Behavioral Health Symposium
Mental Health, Substance Abuse, and Older Adults
Skopje, 21 November 2017, General Population Survey results– launch
Teen vaping in Australia Does it increase smoking risk?
HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVENTION & CARE
Presentation transcript:

Drug addiction: Therapeutic problems in everyday clinical practice E. Mellos Psychiatrist – Psychotherapist Program “ATHENA”, Eginition Hospital, Department of Psychiatry

It is a commonly held belief that substance abuse is determined by biological, psychological, cultural and environmental factors and related with a number of consequences in a personal or social level Despite the fact that the problem of drugs in the EU member states has been stabilised in some respects, various other epidemiologic indicators acknowledge new and adverse challenges, relating to the problem

A) the new patterns of drug use B) the problem of co-morbidity C) the Internet pharmacies D) the specific groups of drug users

The drug situation in Europe - new patterns of drug use Heroin abuse is now relatively stable in many EU countries and the number of new users has fallen since the 1990s Injecting use seems to be decreased in some countries, although in others like the new EU members states it may still be increasing The number of drug-related deaths has shown a modest decline after many years on the rise. Drug-related deaths fell from 8,838 in 2000 to 8,306 in 2001 representing a small but significant 6% decrease

Cocaine use remains an issue of increased concern for many EU countries. Surveys show recent cocaine use (last 12 months) has risen to some extent among young people in Spain, UK, Denmark and Germany Cannabis remains the most commonly used illegal substance in Europe with roughly 20% of adults having tried it at least once in their lifetime Cannabis prevalence rates are higher for young people (15-34) ranging from 15 to 35%

Expect XTC in the last years new substances, such as 4-MTA, PMA, PMMA, Ketamine and GHB, are emerging Overall available data show that European trends in the recent use of ecstasy are still upwards, while trends for recent amphetamine use are more complicated in the majority of countries

B) Comorbidity According to the international literature almost half of the individuals with a substance abuse disorder suffer from another mental disorder Personality disorders have been found in 50-90% of drug dependent patients, affective and anxiety disorders in 20%-60% and psychotic disorders in 5-20%

Both drug treatment and psychiatric services regularly fail to detect individuals with co-morbidity, because the diagnosis is often particularly difficult to make Treatment of psychiatric comorbidity in drug users is regarded as complicated and unrewarding and the prognosis of treatment outcome is often poor and uncertain Treating clients with co-morbidity requires cooperation and coordination between services that are involved in their treatment, including health and social services

C) Internet pharmacies The amount of psychotropic substances have been increasing steadily over the past year and now constitute the vast majority of sales of such illicitly operating Internet pharmacies There is great concern over the fact that the lack of age restrictions with regard to potential customers for these drugs could become a major source for abused prescription medications among children and adolescents Internet sales include substances like opioids (codeine or even fentanyl), stimulants and benzodiazepines

D) Specific groups of drug users During the last decade there is an increased focus on the specific group of addictive population, such as minorities or refugees, prisoners, pregnant women or mothers with children These groups of addicts are usually under-represented in therapeutic treatment facilities and may require specialised interventions

Ethnic minorities or refugees could be reasonably considered one of the more vulnerable groups with respect to drug abuse Factors such as language and cultural barriers are often an obstacle to be granted access to services for people from these groups Preventive and treatment interventions specifically designed for ethnic minorities or refugees are still isolated in most European countries

According to the European epidemiological data the number of problem drug users range from 20-50% of the total prison population, in most member states For a number of addicts prison is merely a place where they continue to use drugs, while others start using drugs in prison or commence the injecting use

Women users consist a heterogeneous group with different characteristics and needs, most of which are not answered by the existing treatment modalities The increase in the rate of women drug users is much higher than the men’s in most countries Women still remain a minority in most drug addiction programmes, especially those who have children The need for the development of specific therapeutic programmes for women should not lead to the conclusion that all women are to be treated separately from men

Conclusions (I) During the last two decades, advances in both neurosciences and behavioral sciences have revolutionised our knowledge about the nature of drug addiction and what to do about it A great number of addicts are out of contact with therapeutic or care services and not adequately helped, the drop-out and relapse rates are quite high and eventually the outcome of treatment of drug dependence are not satisfactory

Conclusions (II) Due to the complexity of the addiction and the pervasive consequences treatment typically involve many components Effective treatment must cover the multiple needs of the individual, not just his/her drug use The current status for treatment is that it must include both counseling or psychotherapy and medications Associated services such as medical, educational, legal, financial and others are important components of comprehensive addition treatment

Conclusions (III) There has been a constant growth in all types of drug treatment since the mid 1990s Substitution treatment has become the most commonly available form of specialised treatment for opiate users Nevertheless, the demand still exceeds the supply in some countries Considering all the above, it could be inferred that therapeutic interventions should be both multiple and diversified. However, they would also require to complement each other and to initiate a continuous dialogue between them